Ensoma, an in vivo cellular engineering company with a mission to advance the future of medicine through one-time therapies, today announced U.K. Medicines and Healthcare Products Regulatory Agency ...
ProBioGen and Spica Therapeutics, a biotechnology company advancing pathogenic macrophage subset-targeted immunotherapies, ...
SAB Biotherapeutics, Inc. (Nasdaq: SABS), a clinical-stage biopharmaceutical company developing human anti-thymocyte immunoglobulin (hATG) for type 1 diabetes (T1D) and other autoimmune diseases, ...
Morning Overview on MSN
Scientists map how bacteria turn steroids into medicines
Scientists are finally tracing, step by step, how bacteria strip down and rebuild steroid molecules into compounds that look a lot like modern drugs. By mapping these microbial assembly lines in the ...
NITI Aayog hopes that by 2035, India’s homegrown quantum computing platforms may help accelerate drug discovery by simulating ...
Every school had a certified genius. They were the valedictorian, the kid who ruined the grading curve, the person whose future seemed like a straight, golden road paved with scholarships and success.
Vertex Pharmaceuticals Incorporated ( VRTX) Citi Annual Global Healthcare Conference 2025 December 3, 2025 9:00 AM EST ...
Daniel Ives You can reverse the age of cells all the way down to zero in just a few weeks. So you can actually take a ...
VectorY Therapeutics, a leader in vectorized antibody therapies for neurodegenerative diseases, announced today that the U.S. Food and Drug Administration (FDA) has cleared the company to proceed with ...
Brent Saunders returned to Bausch + Lomb in 2023 to help address unmet needs in eye care, focusing on innovation and ...
The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing nine new Collaborative Research Centres (CRC) to further support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results